
CAS 910463-68-2
:Sémaglutide
Description :
Sémaglutide est un analogue synthétique du peptide-1 similaire au glucagon (GLP-1), principalement utilisé dans la gestion du diabète de type 2 et de l'obésité. Il se caractérise par sa capacité à augmenter la sécrétion d'insuline en réponse à des niveaux élevés de glucose dans le sang, aidant ainsi au contrôle glycémique. Sémaglutide a une longue demi-vie en raison de sa résistance à la dégradation enzymatique, ce qui permet une administration sous-cutanée une fois par semaine. La substance est généralement administrée sous forme de solution injectable et est connue pour son efficacité à promouvoir la perte de poids en plus de ses effets hypoglycémiants. Son mécanisme d'action implique la stimulation de la libération d'insuline, l'inhibition de la sécrétion de glucagon et le ralentissement de la vidange gastrique, ce qui contribue collectivement à améliorer les résultats métaboliques. Sémaglutide est également associé à un profil de sécurité favorable, bien qu'il puisse avoir des effets secondaires tels que des troubles gastro-intestinaux. En tant que médicament peptide, il est composé de 31 acides aminés et a un poids moléculaire qui reflète sa structure complexe. Dans l'ensemble, Sémaglutide représente une avancée significative dans les options de traitement du diabète et de l'obésité.
- Sermaglutide
Trier par
Degré de pureté (%)
0
100
|
0
|
50
|
90
|
95
|
100
12 produits concernés.
Semaglutide
CAS :Acylated GLP-1 analog with a half-life of 160 h. Semaglutide is under evaluation for the management of diabetes II. Due to its prolonged half-life, the peptide has to be injected only once per week. Bachem provides this product solely for uses within the scope of any statute or law providing for an immunity, exemption, or exception to patent infringement (“Exempted Uses”), including but not limited to 35 U.S.C. § 271(e)(1) in the United States, the Bolar type exemption in Europe, and any corresponding exception to patent infringement in any other country. It is the sole responsibility of the purchaser or user of this product, and the purchaser or user of this product agrees to engage only in such Exempted Uses, and to comply with all applicable intellectual property laws and/or regulations. The purchaser of this product agrees to indemnify Bachem against all claims in connection with the performance of the respective commercial agreement (e.g. supply agreement) and possible infringements of intellectual property rights.Formule :C187H291N45O59Degré de pureté :97.5%Couleur et forme :WhiteMasse moléculaire :4113.64Semaglutide
CAS :Formule :C187H291N45O59Degré de pureté :99%Couleur et forme :SolidMasse moléculaire :4113.5775Ref: IN-DA00H230
1g569,00€2g906,00€5gÀ demander5mg74,00€10mg108,00€25mg142,00€50mg163,00€100mg243,00€250mg363,00€500mg334,00€Semaglutide-d8 Tetratrifluoroacetate
CAS :Formule :C187H283D8N45O59·4C2HF3O2Couleur et forme :White To Off-White SolidMasse moléculaire :4121.69 4*114.02Semaglutide
CAS :Formule :C187H291N45O59Couleur et forme :White To Off-White SolidMasse moléculaire :4113.64Semaglutide-d15 Tetratrifluoroacetate
CAS :Formule :C187H276D15N45O59·4C2HF3O2Masse moléculaire :4128.73 4*114.02Semaglutide
CAS :Semaglutide is a glucagon-like peptide 1 receptor (GLP-1R) agonist(EC50 of 6.2 pM in a reporter assay using BHK cells expressing the human receptor).Formule :C187H291N45O59Degré de pureté :96.92% - 99.78%Couleur et forme :SolidMasse moléculaire :4114Semaglutide
CAS :<p>Anti-diabetic and anti-obesity drug. We also have the heavy labelled material, CRB1301886.<br>Cymit Quimica provides this product solely for uses within the scope of any statute or law providing for an immunity, exemption, or exception to patent infringement (“Exempted Uses”), including but not limited to 35 U.S.C. § 271(e)(1) in the United States, the Bolar type exemption in Europe, and any corresponding exception to patent infringement in any other country. It is the sole responsibility of the purchaser or user of this product, and the purchaser or user of this product agrees to engage only in such Exempted Uses, and to comply with all applicable intellectual property laws and/or regulations. The purchaser of this product agrees to indemnify Cymit Quimica against all claims in connection with the performance of the respective commercial agreement (e.g. supply agreement) and possible infringements of intellectual property rights.</p>Formule :C187H291N45O59Degré de pureté :Min. 99.0 Area-%Couleur et forme :PowderMasse moléculaire :4,113.58 g/molSemaglutide sodium
CAS :<p>Cymit Quimica provides this product solely for uses within the scope of any statute or law providing for an immunity, exemption, or exception to patent infringement (“Exempted Uses”), including but not limited to 35 U.S.C. § 271(e)(1) in the United States, the Bolar type exemption in Europe, and any corresponding exception to patent infringement in any other country. It is the sole responsibility of the purchaser or user of this product, and the purchaser or user of this product agrees to engage only in such Exempted Uses, and to comply with all applicable intellectual property laws and/or regulations. The purchaser of this product agrees to indemnify Cymit Quimica against all claims in connection with the performance of the respective commercial agreement (e.g. supply agreement) and possible infringements of intellectual property rights.</p>Formule :C187H291N45O59•NaxDegré de pureté :Min. 98.0 Area-%Couleur et forme :PowderMasse moléculaire :4,113.58 g/mol






